FDA panel recommends Pfizer RSV vaccine for older adults

The Pfizer RSV vaccine candidate for adults over 60 has been recommended by ...

Can biotech crack the code on pain medications?

Pain is the number one reason most Americans go to the doctor is ...

Will gene therapies for ultra-rare diseases become a cautionary tale – or life-saving products?

For three decades, Genethon, a non-profit research organization, has pioneered development of gene ...

The rise of drug-resistant Shigella offers glimpse into danger AMR poses

A significant increase in the percentage of Shigella infections caused by extensively drug-resistant ...

USDA Agricultural Outlook Forum: SAF, carbon markets, and the future of biotechnology

The U.S. Department of Agriculture (USDA) held the 99th Agricultural Outlook Forum last week, ...

Biosimilars expected to boom in 2023-27, says report

According to a recent report from IQVIA, the market for biosimilars, which mimic ...

BIO CEO testifies in hearing highlighting PBMs’ impact on drug prices

Pharmacy benefit managers (PBMs) were identified as a major driver behind higher prescription drug costs in a congressional hearing that featured testimony from BIO President ...

February 13, 2026

BIO lauds passage of PPRV reauthorization and legislation on PBM reform

February 4, 2026

A female nurse of African decent sits at the bedside of a female patient as she checks in on her during rounds. The patient is dressed comfortably and has a head scarf on to keep warm.

Putting Americans First: No medicine is more expensive than the one patients can’t access

September 12, 2025

LATEST NEWS

Federal Policy

BIO Patient Advocacy Coffee Chat: Act now to be heard on CMS drug pricing

The Medicare drug price “negotiation” process has entered its third year, with some evolution but continued complexity for patients and patient organizations. This year, 15 ...

February 26, 2026

Meet us in Miami for the BIO Investment and Growth Summit

The inaugural Biotechnology Innovation Organization (BIO) Investment and Growth (BIG) Summit kicks off on March 2, 2025, and will convene industry leaders in sunny Miami ...

February 25, 2026

BIO warns MFN models are illegal, ineffective, and a threat to innovation

Proposals to let decisions by other countries control American drug prices are illegal, would reduce the availability of innovative new treatments, and fail to help ...

February 25, 2026

Health

Music Beats Cancer aims to bring everyone to the stage

The Valley of Death is a healthcare crisis, but the nonprofit, Music Beats Cancer, has an innovative way to help solve it, and it starts ...

February 25, 2026

BIO Events

The BIG Summit meets at the intersection of patient advocacy and venture investment

Patient advocacy organizations that leverage venture philanthropy—an approach to philanthropic giving that applies venture capital principles to achieve philanthropic goals—can provide vital funding sources for ...

February 23, 2026